Jäger W, Diedrich M, Sauerbrei W, Wildt L
Department of Obstetrics and Gynecology, University of Erlangen, F.R.G.
Anticancer Res. 1987 Jul-Aug;7(4B):711-5.
Hourly blood sampling for CEA determination was performed in metastatic breast cancer patients before and during medical treatment. Rhythmic fluctuations of marker concentrations could be detected. These oscillations seemed to be independent of the localisation of metastases and the kind of treatment. No relation between cortisol or prolactin and CEA levels became apparent.
在转移性乳腺癌患者接受治疗前及治疗期间,每小时采集血样以测定癌胚抗原(CEA)。可检测到标志物浓度的节律性波动。这些波动似乎与转移灶的位置及治疗方式无关。未发现皮质醇或催乳素与CEA水平之间存在明显关联。